The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment
Abstract
PURPOSE: The purpose of this American Urological Association (AUA)/Society of Urologic Oncology (SUO) guideline amendment is to provide a useful reference on the effective evidence-based treatment strategies for non-muscle invasive bladder cancer (NMIBC). MATERIALS AND METHODS: In 2023, the NMIBC guideline was updated through the AUA amendment process in which newly published literature is reviewed and integrated into previously published guidelines in an effort to maintain currency. The amendment allowed for the incorporation of additional literature released since the previous 2020 amendment. The updated search gathered literature from July 2019 to May 2023. This review identified 1918 abstracts, of which 75 met inclusion criteria.When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) in support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions. RESULTS: Updates were made to statements on variant histologies, urine markers after diagnosis of bladder cancer, intravesical therapy, BCG maintenance, enhanced cystoscopy, and future directions. Further revisions were made to the methodology and reference sections as appropriate. CONCLUSIONS: This guideline seeks to improve clinicians' ability to evaluate and treat patients with NMIBC based on currently available evidence. Future studies will be essential to further support or refine these statements to improve patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
SYLVESTER, R. J., OOSTERLINCK, W., & van der MEIJDEN, A. P. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000125486.92260.b2 · Cited by 743
The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome
Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C., & Fair, W. R. (1997) · Journal of Urology · doi:10.1097/00005392-199707000-00017 · Cited by 549
Boorjian, S. A., Alemozaffar, M., Konety, B. R., Shore, N. D., Gomella, L. G., Kamat, A. M., Bivalacqua, T. J., Montgomery, J. S., Lerner, S. P., Busby, J. E., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30540-4 · Cited by 480
Self-citationPalou, J., Sylvester, R. J., Faba, O. R., Parada, R., Peña, J. A., Algaba, F., & Villavicencio, H. (2012) · European Urology · doi:10.1016/j.eururo.2011.10.029 · Cited by 259
Perlis, N., Zlotta, A. R., Beyene, J., Finelli, A., Fleshner, N. E., & Kulkarni, G. S. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.009 · Cited by 161
Kipp, B. R., Karnes, R. J., Brankley, S. M., Harwood, A. R., Pankratz, V. S., Sebo, T. J., BLUTE, M. M., Lieber, M. M., Zincke, H., & Halling, K. C. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000149825.83180.a4 · Cited by 120
Kim, H. S., Kim, M., Jeong, C. W., Kwak, C. H., Kim, H. H., & Ku, J. H. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.05.008 · Cited by 76
Rose, K. M., Huelster, H. L., Meeks, J. J., Faltas, B. M., Sonpavde, G., Lerner, S. P., Ross, J. S., Spiess, P. E., Grass, G. D., Jain, R., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00725-2 · Cited by 73
Metadata
- Authors
- Holzbeierlein, J. M., Bixler, B. R., Buckley, D. I., Chang, S. S., Holmes, R., James, A. C., Kirkby, E., McKiernan, J. M., & Schuckman, A. K.
- Venue
- Journal of Urology
- Published
- 2024-04
- Volume
- 211
- Issue
- 4
- Pages
- 533-538
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W4391169343
- Cited by
- 430
- References
- 19
- FWCI
- 164.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. https://app.cochat.ai/papers/10.1097/ju.0000000000003846
- The paper
- Holzbeierlein, J. M., Bixler, B. R., Buckley, D. I., Chang, S. S., Holmes, R., James, A. C., Kirkby, E., McKiernan, J. M., & Schuckman, A. K. (2024). Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. Journal of Urology. https://doi.org/10.1097/ju.0000000000003846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.